Detalles de la búsqueda
1.
Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019.
Value Health
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38663800
2.
Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virus.
J Viral Hepat
; 30(9): 756-764, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37377165
3.
Evaluation of an Osteoporosis Outreach Program for Men With a Fragility Fracture and Their Physicians.
Med Care
; 59(2): 148-154, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33273290
4.
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals.
Pharmacoecon Open
; 8(2): 221-233, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100074
5.
Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece.
J Comp Eff Res
; 13(4): e230090, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38317634
6.
Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low-level viremia in Saudi Arabia.
Saudi J Gastroenterol
; 30(1): 23-29, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417192
7.
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study.
Vaccines (Basel)
; 12(2)2024 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400166
8.
Economic burden of COVID-19 for employers and employees in the United States.
J Med Econ
; 27(1): 267-278, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38294896
9.
Real-world value of direct-acting antivirals for hepatitis C at Kaiser Permanente Southern California.
Am J Manag Care
; 29(10): e299-e306, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870551
10.
The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review.
J Med Econ
; 26(1): 1519-1531, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964554
11.
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy.
Vaccines (Basel)
; 11(11)2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38006001
12.
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US.
Healthcare (Basel)
; 11(20)2023 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37893865
13.
Importance of Time Point-Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses.
Clin Ther
; 44(1): 81-97, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058055
14.
Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.
J Manag Care Spec Pharm
; 28(10): 1138-1148, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125059
15.
Variability in Cinacalcet Prescription across US Hemodialysis Facilities.
Clin J Am Soc Nephrol
; 14(2): 241-249, 2019 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665922
16.
Limitations of anticholinergic cycling in patients with overactive bladder (OAB) with urinary incontinence (UI): results from the CONsequences of Treatment Refractory Overactive bLadder (CONTROL) study.
Int Urol Nephrol
; 48(7): 1029-36, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032397
17.
Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics.
J Manag Care Spec Pharm
; 22(4): 406-13, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27023694
Resultados
1 -
17
de 17
1
Próxima >
>>